AcelRx Pharmaceuticals, Inc. focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet. ZALVISO is a pre-programmed and patient-controlled analgesia system.
Market Cap | 8.12 Million | Shares Outstanding | 7.449 Million | Avg 30-day Volume | 141.678 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -3.14 |
Price to Revenue | 2.0767 | Debt to Equity | 0.233 | EBITDA | -27.533 Million |
Price to Book Value | 0.3364 | Operating Margin | -1393.6281 | Enterprise Value | -5.244 Million |
Current Ratio | 1.834 | EPS Growth | 0 | Quick Ratio | 1.411 |
1 Yr BETA | -2.5234 | 52-week High/Low | 4.59 / 0.18 | Profit Margin | -1486.5626 |
Operating Cash Flow Growth | 24.5354 | Altman Z-Score | -26.1744 | Free Cash Flow to Firm | -101.158 Million |
Earnings Report | 2023-08-10 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
DASU BADRI N CHIEF ENGINEERING OFFICER |
|
18,771 | 2023-03-03 | 3 |
PALMER PAMELA P CHIEF MEDICAL OFFICER |
|
43,315 | 2023-03-03 | 3 |
ASADORIAN RAFFI CHIEF FINANCIAL OFFICER |
|
22,081 | 2023-03-03 | 3 |
ANGOTTI VINCENT J. CHIEF EXECUTIVE OFFICER |
|
63,836 | 2023-03-03 | 4 |
|
67,750 | 2022-07-15 | 1 | |
|
67,750 | 2022-07-15 | 1 | |
|
242,750 | 2022-07-15 | 1 | |
|
61,500 | 2022-07-15 | 1 | |
|
125,250 | 2022-07-15 | 1 | |
|
68,750 | 2022-07-15 | 1 | |
|
71,500 | 2022-07-15 | 1 | |
|
281,250 | 2021-06-17 | 0 | |
HAMEL LAWRENCE G CHIEF DEVELOPMENT OFFICER |
|
157,564 | 2020-02-11 | 0 |
|
0 | 2018-06-14 | 0 | |
|
0 | 2018-05-21 | 0 | |
SAIA JOHN G. GENERAL COUNSEL AND SECRETARY |
|
0 | 2018-04-16 | 0 |
|
No longer subject to file | 2017-06-19 | 0 | |
MORRIS TIMOTHY E CHIEF FINANCIAL OFFICER |
|
0 | 2017-02-07 | 0 |
MITCHELL JANE WRIGHT CHIEF LEGAL OFFICER |
|
0 | 2017-02-07 | 0 |
YATRA ONLINE, INC. CHIEF FINANCIAL OFFICER |
|
0 | 2014-03-25 | 0 |
SKYLINE VENTURE PARTNERS QUALIFIED PURCHASER FUND IV L P |
|
No longer subject to file | 2014-03-07 | 0 |
|
134,567 | 2014-03-02 | 0 | |
WELCH JAMES H CHIEF FINANCIAL OFFICER |
|
0 | 2014-02-04 | 0 |
CHUNG DAVID CHIEF COMMERCIAL OFFICER |
|
0 | 2014-02-04 | 0 |
|
2,507,974 | 2013-09-19 | 0 | |
|
0 | 2012-07-24 | 0 | |
|
8,206,351 | 2012-05-29 | 0 | |
SKYLINE VENTURE PARTNERS QUALIFIED PURCHASER FUND IV L P |
|
4,418,161 | 2012-05-29 | 0 |
|
0 | 2011-02-16 | 0 | |
|
0 | 2011-02-16 | 0 | |
|
8,177,073 | 2011-02-16 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 22:15:04 UTC | -7.6694 | 12.7394 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 21:45:04 UTC | -7.6694 | 12.7394 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 21:15:05 UTC | -7.6694 | 12.7394 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 20:45:03 UTC | -7.6694 | 12.7394 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 20:15:04 UTC | -7.4271 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 19:45:03 UTC | -7.4271 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 19:15:04 UTC | -7.4271 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 18:45:03 UTC | -7.4271 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 18:15:04 UTC | -7.4271 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 17:45:04 UTC | -7.4271 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 17:15:04 UTC | -7.4271 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 16:45:04 UTC | -7.4371 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 16:15:04 UTC | -7.4371 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 15:45:03 UTC | -7.4371 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 15:15:04 UTC | -7.4371 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 14:45:04 UTC | -7.4371 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 14:15:04 UTC | -7.4371 | 12.4971 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 13:45:04 UTC | -5.4358 | 10.4958 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 13:15:04 UTC | -5.4358 | 10.4958 | 100000 |
ACELRX PHARMACEUTICALS INC ACRX | 2023-06-01 12:45:04 UTC | -5.4358 | 10.4958 | 100000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | ACRX | -1070.0 shares, $-704.06 | 2023-03-31 | N-PORT |